BOK Financial Private Wealth’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

BOK Financial Private Wealth’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,333	Closed	-$30.2K	–	568
2024 Q4	$30.2K	Hold	1,333	–	–	﹤0.01%	300
2024 Q3	$32.8K	Hold	1,333	–	–	﹤0.01%	305
2024 Q2	$30.8K	Hold	1,333	–	–	﹤0.01%	308
2024 Q1	$32.1K	Hold	1,333	–	–	﹤0.01%	293
2023 Q4	$30.7K	Hold	1,333	–	–	﹤0.01%	291
2023 Q3	$27.1K	Hold	1,333	–	–	﹤0.01%	279
2023 Q2	$31.1K	Hold	1,333	–	–	﹤0.01%	263
2023 Q1	$31K	Hold	1,333	–	–	﹤0.01%	281
2022 Q4	$33.6K	Hold	1,333	–	–	﹤0.01%	263
2022 Q3	$35K	Hold	1,333	–	–	﹤0.01%	264
2022 Q2	$39K	Buy	+1,333	New	+$39.8K	﹤0.01%	262

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

CCA

Cora Capital Advisors Marlton, New Jersey $302M AUM 16.46% 1-Year Est. Return

BOK Financial Private Wealth's IDNA Position: Q1 2025 in Review

BOK Financial Private Wealth sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2025, closing a stake of 1,333 shares — an estimated $30.2K sold.

BOK Financial Private Wealth first reported a position in IDNA in Q2 2022 and held it in 11 quarters. The position peaked at $39K in Q2 2022. 48 funds tracked by Wall St. Rank hold IDNA as of Q1 2025.

BOK Financial Private Wealth reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2025 after selling out during the quarter.
BOK Financial Private Wealth sold 1,333 iShares Genomics Immunology and Healthcare ETF shares in Q1 2025, an estimated $30.2K.
BOK Financial Private Wealth first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2022 and held it in 11 quarters.
BOK Financial Private Wealth's iShares Genomics Immunology and Healthcare ETF position peaked at $39K in Q2 2022.
48 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2025.

Based on BOK Financial Private Wealth's 13F filing for Q1 2025, filed 14 May 2025.